Cargando…
Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression
A growing body of research associates the oral microbiome and oral cancer. Well-characterized clinical samples with outcome data are required to establish relevant associations between the microbiota and disease. The objective of this study was to characterize the community variations and the functi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080811/ https://www.ncbi.nlm.nih.gov/pubmed/37024828 http://dx.doi.org/10.1186/s12903-023-02911-5 |
_version_ | 1785020991959728128 |
---|---|
author | Wright, Robyn J. Pewarchuk, Michelle E. Marshall, Erin A. Murrary, Benjamin Rosin, Miriam P. Laronde, Denise M. Zhang, Lewei Lam, Wan L. Langille, Morgan G. I. Rock, Leigha D. |
author_facet | Wright, Robyn J. Pewarchuk, Michelle E. Marshall, Erin A. Murrary, Benjamin Rosin, Miriam P. Laronde, Denise M. Zhang, Lewei Lam, Wan L. Langille, Morgan G. I. Rock, Leigha D. |
author_sort | Wright, Robyn J. |
collection | PubMed |
description | A growing body of research associates the oral microbiome and oral cancer. Well-characterized clinical samples with outcome data are required to establish relevant associations between the microbiota and disease. The objective of this study was to characterize the community variations and the functional implications of the microbiome in low-grade oral epithelial dysplasia (OED) using 16S rRNA gene sequencing from annotated archival swabs in progressing (P) and non-progressing (NP) OED. We characterised the microbial community in 90 OED samples — 30 swabs from low-grade OED that progressed to cancer (cases) and 60 swabs from low-grade OED that did not progress after a minimum of 5 years of follow up (matched control subjects). There were small but significant differences between P and NP samples in terms of alpha diversity as well as beta diversity in conjunction with other clinical factors such as age and smoking status for both taxa and functional predictions. Across all samples, the most abundant genus was Streptococcus, followed by Haemophilus, Rothia, and Neisseria. Taxa and predicted functions were identified that were significantly differentially abundant with progression status (all Ps and NPs), when samples were grouped broadly by the number of years between sampling and progression or in specific time to progression for Ps only. However, these differentially abundant features were typically present only at low abundances. For example, Campylobacter was present in slightly higher abundance in Ps (1.72%) than NPs (1.41%) and this difference was significant when Ps were grouped by time to progression. Furthermore, several of the significantly differentially abundant functions were linked to the Campylobacteraceae family in Ps and may justify further investigation. Larger cohort studies to further explore the microbiome as a potential biomarker of risk in OED are warranted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12903-023-02911-5. |
format | Online Article Text |
id | pubmed-10080811 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100808112023-04-08 Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression Wright, Robyn J. Pewarchuk, Michelle E. Marshall, Erin A. Murrary, Benjamin Rosin, Miriam P. Laronde, Denise M. Zhang, Lewei Lam, Wan L. Langille, Morgan G. I. Rock, Leigha D. BMC Oral Health Research A growing body of research associates the oral microbiome and oral cancer. Well-characterized clinical samples with outcome data are required to establish relevant associations between the microbiota and disease. The objective of this study was to characterize the community variations and the functional implications of the microbiome in low-grade oral epithelial dysplasia (OED) using 16S rRNA gene sequencing from annotated archival swabs in progressing (P) and non-progressing (NP) OED. We characterised the microbial community in 90 OED samples — 30 swabs from low-grade OED that progressed to cancer (cases) and 60 swabs from low-grade OED that did not progress after a minimum of 5 years of follow up (matched control subjects). There were small but significant differences between P and NP samples in terms of alpha diversity as well as beta diversity in conjunction with other clinical factors such as age and smoking status for both taxa and functional predictions. Across all samples, the most abundant genus was Streptococcus, followed by Haemophilus, Rothia, and Neisseria. Taxa and predicted functions were identified that were significantly differentially abundant with progression status (all Ps and NPs), when samples were grouped broadly by the number of years between sampling and progression or in specific time to progression for Ps only. However, these differentially abundant features were typically present only at low abundances. For example, Campylobacter was present in slightly higher abundance in Ps (1.72%) than NPs (1.41%) and this difference was significant when Ps were grouped by time to progression. Furthermore, several of the significantly differentially abundant functions were linked to the Campylobacteraceae family in Ps and may justify further investigation. Larger cohort studies to further explore the microbiome as a potential biomarker of risk in OED are warranted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12903-023-02911-5. BioMed Central 2023-04-06 /pmc/articles/PMC10080811/ /pubmed/37024828 http://dx.doi.org/10.1186/s12903-023-02911-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wright, Robyn J. Pewarchuk, Michelle E. Marshall, Erin A. Murrary, Benjamin Rosin, Miriam P. Laronde, Denise M. Zhang, Lewei Lam, Wan L. Langille, Morgan G. I. Rock, Leigha D. Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression |
title | Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression |
title_full | Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression |
title_fullStr | Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression |
title_full_unstemmed | Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression |
title_short | Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression |
title_sort | exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080811/ https://www.ncbi.nlm.nih.gov/pubmed/37024828 http://dx.doi.org/10.1186/s12903-023-02911-5 |
work_keys_str_mv | AT wrightrobynj exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression AT pewarchukmichellee exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression AT marshallerina exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression AT murrarybenjamin exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression AT rosinmiriamp exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression AT larondedenisem exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression AT zhanglewei exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression AT lamwanl exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression AT langillemorgangi exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression AT rockleighad exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression |